Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression

Tuesday, May 14, 2024 1 min read

Key Takeaway: Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression

Full Press Release Details

Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression.